US Patent Issued to MEDIGEN VACCINE BIOLOGICS, DYNAVAX TECHNOLOGIES on May 13 for "Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" (Taiwanese, American Inventors)

Posted On: 2025-06-12

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,296,002, issued on May 13, was assigned to MEDIGEN VACCINE BIOLOGICS Corp. (Zhubei, Taiwan) and DYNAVAX TECHNOLOGIES Corp. (Emeryville, Calif.).

"Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" was invented by Tsun-Yung Kuo (I-Lan County, Taiwan), Charles Chen (Taipei, Taiwan), Chung-Chin Wu (I-Lan County, Taiwan), Yi-Jiun Lin (Taipei, Taiwan), Meei-Yun Lin (Taipei, Taiwan), Yu-Chi Wu (Taipei, Taiwan), John Darren Campbell (Emeryville, Calif.), Robert S. Janssen (Emeryville, Calif.), David Novack (Emeryville, Calif.), Robert Coffman (Emeryville, Calif.) and Paula Traquina (Emeryville, Calif.).

According to the abstract* released by the U....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to MEDIGEN VACCINE BIOLOGICS, DYNAVAX TECHNOLOGIES on May 13 for "Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" (Taiwanese, American Inventors)